Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

• Version
• Download 0
• File Size 780 KB
• File Count 0
• Create Date 22/08/2021
• Last Updated 22/08/2021

Whether a broadly neutralizing antibody (bnAb) can be used to prevent human immunodeficiency virus type 1 (HIV-1) acquisition is unclear.